DDEL-15. NANOTHERAPEUTIC TARGETING OF TUMOR ENDOTHELIUM FOR ENHANCING DRUG DELIVERY PAST THE BLOOD-BRAIN BARRIER

OBJECTIVE: The Sonic Hedgehog (SHH) medulloblastoma subgroup accounts for ~25% of all cases and has an intermediate prognosis. Current therapies result in devastating morbidities including intellectual disability and secondary malignancies. Although molecularly targeted agents against the SHH pathwa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiguchi, Hiro, Tylawsky, Daniel, Vaynshteyn, Jake, Gerwin, Jeffrey, Manzari, Mandana, Shah, Janki, Li, Na, Shamay, Yosi, Greenblatt, Matthew, Heller, Daniel, Raju, Praveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Drug Delivery/Pharmacokinetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715705/
http://dx.doi.org/10.1093/neuonc/noaa222.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715705/
http://dx.doi.org/10.1093/neuonc/noaa222.050

Ejemplares similares